Antiviral therapy for the treatment of HHV-6-associated syndromes after transplant

Masao Ogata; Tuan L Phan; Takahiro Fukuda

doi:10.1111/ajt.15069

Antiviral therapy for the treatment of HHV-6-associated syndromes after transplant

Am J Transplant. 2019 Jan;19(1):306-307. doi: 10.1111/ajt.15069. Epub 2018 Sep 12.

Authors

Masao Ogata¹, Tuan L Phan^{2

3}, Takahiro Fukuda⁴

Affiliations

¹ Department of Hematology, Oita University Faculty of Medicine, Oita, Japan.
² Department of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, LA, USA.
³ HHV-6 Foundation, Santa Barbara, CA, USA.
⁴ Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.

PMID: 30102463
DOI: 10.1111/ajt.15069

No abstract available

Keywords: antibiotic: antiviral-ganciclovir/valganciclovir; bone marrow/hematopoietic stem cell transplantation; clinical research/practice; encephalopathy; infection and infectious agents - viral: human herpesvirus 6 (HHV-6); infectious disease; liver transplantation/hepatology.

Publication types

Letter
Comment

MeSH terms

Antiviral Agents*
Control Groups
Cord Blood Stem Cell Transplantation*
Encephalitis*
Foscarnet
Ganciclovir
Herpesvirus 6, Human*
Humans
Prospective Studies
Syndrome

Substances

Antiviral Agents
Foscarnet
Ganciclovir